Guilhem Roubaud
Impact in
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
- Oncology top 5%
- PARP inhibition in cancer therapy
Papers in
-
- Prostate Cancer Treatment and Research 74
- Prostate Cancer Diagnosis and Treatment 23
- Renal cell carcinoma treatment 7
- Oncology 40
- PARP inhibition in cancer therapy 18
- Cancer Immunotherapy and Biomarkers 9
- Co-authors
- Paul Sargos (45 shared papers)Karim Fizazi (32 shared papers)Shahneen Sandhu (13 shared papers)Kim N. (11 shared papers)David Olmos (13 shared papers)Antoine Thiery-Vuillemin (11 shared papers)Johann S. de Bono (10 shared papers)Neal D. Shore (10 shared papers)
- Journals
- Journal of Clinical Oncology (37 papers)Annals of Oncology (20 papers)European Journal of Cancer (6 papers)European Urology Oncology (5 papers)World Journal of Urology (4 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Guilhem Roubaud
120 papers receiving 1.6k citations
Guilhem Roubaud's Hit Papers
Peers
Comparison fields: 5 of 66
- Pulmonary and Respiratory Medicine 982
- Oncology 519
- Cancer Research 224
- Radiology, Nuclear Medicine and Imaging 157
- Surgery 251
Countries citing papers authored by Guilhem Roubaud
This map shows the geographic impact of Guilhem Roubaud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guilhem Roubaud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guilhem Roubaud more than expected).
Fields of papers citing papers by Guilhem Roubaud
This network shows the impact of papers produced by Guilhem Roubaud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guilhem Roubaud. The network helps show where Guilhem Roubaud may publish in the future.
Co-authors
The 25 scholars most cited alongside Guilhem Roubaud, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 138 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer Hit paper breakdown → | 2020 | 489 |
| 2 | 2021 | 101 | |
| 3 | 2022 | 82 | |
| 4 | 2023 | 42 | |
| 5 | 2016 | 37 | |
| 6 | 2019 | 32 | |
| 7 | 2021 | 31 | |
| 8 | 2021 | 31 | |
| 9 | 2022 | 30 | |
| 10 | 2021 | 29 | |
| 11 | 2018 | 29 | |
| 12 | 2014 | 28 | |
| 13 | 2022 | 27 | |
| 14 | 2019 | 27 | |
| 15 | 2021 | 26 | |
| 16 | 2015 | 24 | |
| 17 | 2018 | 21 | |
| 18 | 2011 | 20 | |
| 19 | 2013 | 19 | |
| 20 | 2022 | 19 |
About Guilhem Roubaud
Guilhem Roubaud is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 138 papers that have together received 1.6k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (74 papers), Bladder and Urothelial Cancer Treatments (26 papers), Prostate Cancer Diagnosis and Treatment (23 papers), Radiopharmaceutical Chemistry and Applications (23 papers), PARP inhibition in cancer therapy (18 papers), Testicular diseases and treatments (9 papers), Cancer Immunotherapy and Biomarkers (9 papers) and Renal cell carcinoma treatment (7 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (982 citations), Oncology (519 citations), Cancer Research (224 citations), Radiology, Nuclear Medicine and Imaging (157 citations) and Surgery (251 citations). Guilhem Roubaud has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Paul Sargos, Karim Fizazi, Shahneen Sandhu, Kim N., David Olmos, Antoine Thiery-Vuillemin, Johann S. de Bono, Neal D. Shore, Oliver Sartor and Mustafa Özgüroğlu. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, European Urology Oncology and World Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.